ABX01
/ Centauri Therap
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
October 20, 2022
"ABX-01 has dual MOA: immunotherapeutic (recruits anti-Gal antibodies) and intrinsic antibacterial activity. #IDWeek2022"
(@LordAlirezaF)
Infectious Disease
October 20, 2022
"One advantage of ABX-01's dual MOA is that it requires less dose. #IDWeek2022"
(@LordAlirezaF)
Infectious Disease
October 20, 2022
"ABX-01 has a broad spectrum, including anti-pseudomonal activity #IDWeek2022"
(@LordAlirezaF)
Infectious Disease
October 08, 2022
"#idweek2022 is around the corner. The antibacterial and antifungal pipelines sessions are back! novel antibacterials to be featured: Ibezalpostat, ABX-01, Epetraborole, Gepotidacin, SER-109 and cefepime-taniborbactam @IDSAInfo @JohnRex_NewAbx @davidvanduin"
(@SuperBugDoc)
Infectious Disease
July 23, 2022
Pipeline Presentation 1
(IDWeek 2022)
- No abstract available
Infectious Disease
1 to 5
Of
5
Go to page
1